APA (7th ed.) Citation

Eigentler, T., Thomas, I., Samoylenko, I., Erdmann, M., Heinzerling, L., Ochsenreither, S., . . . Gnad-Vogt, U. (2025). Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma. Journal for ImmunoTherapy of Cancer, 13(2), . https://doi.org/10.1136/jitc-2024-009352

Chicago Style (17th ed.) Citation

Eigentler, Thomas, et al. "Phase I Study of Intratumoral Administration of CV8102 in Patients with Advanced Melanoma, Squamous Cell Carcinoma of the Skin, Squamous Cell Carcinoma of the Head and Neck, or Adenoid Cystic Carcinoma." Journal for ImmunoTherapy of Cancer 13, no. 2 (2025). https://doi.org/10.1136/jitc-2024-009352.

MLA (9th ed.) Citation

Eigentler, Thomas, et al. "Phase I Study of Intratumoral Administration of CV8102 in Patients with Advanced Melanoma, Squamous Cell Carcinoma of the Skin, Squamous Cell Carcinoma of the Head and Neck, or Adenoid Cystic Carcinoma." Journal for ImmunoTherapy of Cancer, vol. 13, no. 2, 2025, https://doi.org/10.1136/jitc-2024-009352.